The aim of the study is to demonstrate the feasibility and validity of a saliva based home surveillance monitoring test for SARS-CoV-2 infection. Participants will be asked to carry out as many tests as are included in the bag they are provided, on a daily basis until they are used up.
Device: Saliva test kit
Kit including tube with closed reagents using loop-mediated isothermal amplification (LAMP) assay to detect SARS-CoV-2 virus.
Other Name: SnapDx
Inclusion Criteria:
- Hospitalized patients
- Hospitalized at Stanford Health Care for COVID-related complications and tested
positive for SARS-CoV-2 with a PCR-based test
- Able to understand and consent to study and with a clinical trajectory likely to
be consistent with multi-day participation
- High-risk/positive population
- Seeking testing for suspected COVID or a participant in a study of COVID-positive
outpatients
- Own an internet-enabled phone or device capable of loading web pages, receiving
text messages, and taking/uploading photos.
- Willing to participate in the study for 6 months
- Low-risk population
- Own an internet-enabled phone or device capable of loading web pages, receiving
text messages, and taking/uploading photos.
- Willing to participate in the study for 6 months
Exclusion Criteria:
- All participants:
- Participants with salivary gland dysfunction (including patients with Sjogren's
disease or those with xerostomia associated with lupus or rheumatoid arthritis)
- Participants will not be eligible if they identify any reason they are unable to
participate in the study
- High-risk/positive population
- Participants who have color blindness
- Participants unable to operate the SnapDx device
- Low-risk population
- Participants with prior confirmed SARS-CoV-2 infection
- Participants who have color blindness
- Participants unable to operate the SnapDx device
SHC Valley Care
Pleasanton, California, United States
Stanford University
Stanford, California, United States
Study Team
650-374-0085
snapdxsupport@stanford.edu